Generic medicine

Ondansetron 2mg/ml Injection

Reviewed educational reference: what Ondansetron is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Ondansetron
Strength
2mg/ml
Dosage form
Injection
Drug class
5-HT3 receptor antagonist

Related products

No reviewed products are currently published for this generic.

Ondansetron is a potent, highly selective 5-HT3 receptor antagonist used primarily to prevent and treat nausea and vomiting. It is frequently administered in clinical settings to manage symptoms induced by cytotoxic chemotherapy, radiotherapy, and post-operative recovery. By blocking serotonin receptors in the central and peripheral nervous systems, Ondansetron 2mg/ml Injection effectively interrupts the emetic reflex arc.

At a glance

Quick look

Ondansetron 2mg/ml Injection contains Ondansetron, a potent antiemetic agent.

How it works

It works by blocking serotonin receptors to prevent nausea and vomiting.

Who it is for

It is primarily used for chemotherapy and post-operative recovery.

Uses it for
Chemotherapy nauseaRadiotherapy nauseaPost-operative vomitingAcute nauseaEmetogenic procedure supportClinical antiemetic therapy

Uses of Ondansetron

  • Prevention of chemotherapy-induced nausea and vomiting (CINV).
  • Prevention of radiotherapy-induced nausea and vomiting (RINV).
  • Management of post-operative nausea and vomiting (PONV).
  • Treatment of established nausea and vomiting in clinical settings.
  • Supportive care for patients undergoing emetogenic medical procedures.
  • Reduction of gastrointestinal distress in acute clinical environments.

Benefits of Ondansetron

Effective Symptom Control
The primary benefit of Ondansetron 2mg/ml Injection is its ability to provide rapid and sustained relief from severe nausea and vomiting. Unlike older antiemetics, it does not cause significant sedation or extrapyramidal side effects, making it a preferred choice for patients who need to remain alert during their recovery or treatment phase.

Targeted Mechanism of Action
Because Ondansetron 2mg/ml Injection specifically targets 5-HT3 receptors, it avoids the broad-spectrum side effects associated with dopamine or histamine antagonists. This specificity allows for a cleaner safety profile, particularly in oncology patients who are already dealing with the systemic stress of chemotherapy. Its predictable pharmacokinetic profile ensures that healthcare providers can dose it accurately based on the emetogenic potential of the patient's treatment.

Side effects of Ondansetron

While generally well-tolerated, Ondansetron 2mg/ml Injection may cause side effects in some individuals. The most frequently reported issue is headache, which is typically mild to moderate in intensity. Constipation is another common observation, often requiring dietary adjustments or stool softeners if it persists. Some patients may experience a sensation of warmth or flushing immediately following the intravenous administration of the injection.

More serious, though rare, side effects include cardiac rhythm disturbances, specifically QT interval prolongation. This is why clinicians monitor patients with pre-existing heart conditions or electrolyte imbalances closely. Rarely, hypersensitivity reactions such as skin rashes or bronchospasm may occur. If you notice any signs of an allergic reaction, such as swelling of the face or difficulty breathing, seek immediate medical attention. Most side effects are transient and resolve once the medication is discontinued or the course of treatment is completed.

Side effectHow commonHow severeWhat to do
HeadacheVery commonMildTake simple analgesics as advised by your doctor.
ConstipationCommonModerateIncrease fluid and fiber intake.
QT ProlongationRareSeverePerform ECG monitoring.

How to manage side effects

Headache

  • 1. Assess severity.
  • 2. Recommend paracetamol if appropriate.
  • 3. Monitor for persistence.

Constipation

  • 1. Review dietary habits.
  • 2. Consider stool softeners if necessary.
  • 3. Ensure adequate hydration.

QT Prolongation

  • 1. Discontinue the drug.
  • 2. Correct electrolyte imbalances.
  • 3. Consult a cardiologist immediately.

How to use Ondansetron

  • Ondansetron 2mg/ml Injection is administered by a healthcare professional via slow intravenous injection or infusion.
  • The dosage is determined by your physician based on your weight, the type of medical procedure, and your overall health status.
  • Ensure that you inform your medical team about any other medications you are currently taking before the injection is given.
  • The injection site will be monitored by nursing staff to ensure there is no irritation or local reaction.
  • Do not attempt to self-administer this medication; it must be handled in a controlled clinical environment.

Special population advice

Kidney impairment

  • No routine dose adjustment required.
  • Monitor patients with severe renal failure.

Liver impairment

  • Maximum daily dose of 8mg for severe hepatic impairment.
  • Monitor liver function tests.

Children

  • Dose based on body surface area or weight.
  • Consult pediatric protocols for specific age groups.

Elderly

  • Use with caution in patients over 65.
  • Monitor for cardiac rhythm changes.

How Ondansetron works

Ondansetron works by selectively blocking the 5-HT3 serotonin receptors located on the vagus nerve terminals in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By inhibiting these receptors, it prevents the transmission of signals that trigger the vomiting reflex, thereby providing significant relief from nausea.

What if you miss or exceed a dose?

If you miss a dose

Since Ondansetron 2mg/ml Injection is administered by healthcare professionals in a clinical setting, missing a dose is unlikely. If you are scheduled for a dose and it is delayed, inform your nurse or doctor immediately so they can adjust your treatment schedule accordingly.

In case of overdose

An overdose of Ondansetron 2mg/ml Injection is rare in a clinical setting. Symptoms may include visual disturbances, severe constipation, or cardiac rhythm changes. If an overdose is suspected, medical staff will provide supportive care and monitor your heart rhythm using an ECG. There is no specific antidote for this medication.

AntidoteNo specific antidote

Management is purely symptomatic and supportive.

Cardiac Monitoring
Perform continuous ECG monitoring to detect QT prolongation.
Supportive Care
Maintain airway and provide intravenous fluids as needed.
Symptom Management
Treat specific symptoms like visual disturbances or severe constipation.
Observation
Keep the patient under observation until symptoms resolve.

Safety and precautions

When to avoid Ondansetron

Do not take if you
  • Hypersensitivity

    Known allergy to Ondansetron or other 5-HT3 antagonists.

  • Apomorphine use

    Concurrent use with apomorphine is strictly contraindicated.

Use with caution
  • Cardiac disease

    Risk of QT prolongation and arrhythmias.

  • Electrolyte imbalance

    Correct hypokalemia or hypomagnesemia before administration.

  • Hepatic impairment

    Reduce dose in patients with severe liver disease.

  • Gastrointestinal obstruction

    Monitor for signs of bowel obstruction.

Safety at a glance

AlcoholUse with caution

Alcohol may worsen nausea and increase the risk of side effects.

PregnancyConsult your doctor

Use only if clearly indicated and under strict medical supervision.

BreastfeedingConsult your doctor

Consult your doctor as the drug may pass into breast milk.

DrivingSafe

Generally does not affect alertness, but avoid driving if you feel unwell.

KidneySafe

No dose adjustment is typically required for renal impairment.

LiverUse with caution

Dose reduction may be necessary in patients with severe hepatic impairment.

AllergyUnsafe

Do not use if you have a known hypersensitivity to 5-HT3 antagonists.

ChildrenUse with caution

Use only under pediatric specialist guidance with weight-based dosing.

ElderlyUse with caution

Monitor closely for cardiac effects and constipation.

Interactions

With other medicines

Amiodarone

Major

Changes the medicine’s effect

What can happen: Increased risk of QT prolongation and Torsades de Pointes.

What to do: Avoid concurrent use or monitor ECG closely.

Rifampicin

Moderate

Changes how the medicine is processed

What can happen: Reduced plasma concentration of Ondansetron.

What to do: Monitor for reduced antiemetic efficacy.

Apomorphine

Major

Should not be combined

What can happen: Severe hypotension and loss of consciousness.

What to do: Do not use together under any circumstances.

With food and drink

  • None specificMinor

    No significant food interactions are known for this injection.

  • Grapefruit juiceMinor

    May theoretically alter hepatic metabolism enzymes, though clinically insignificant for IV administration.

If you have another condition

  • Congenital long QT syndrome

    Avoid use due to high risk of life-threatening arrhythmias.

  • Severe hepatic impairment

    Requires dose adjustment to prevent accumulation.

Effect on laboratory tests

  • ECG

    <b>QT interval prolongation</b>

    Monitor heart rhythm during treatment.

Quick tips

  • Stay hydrated if you experience constipation after your treatment.
  • Inform your doctor if you have a history of heart rhythm problems or low potassium levels.
  • Report any dizziness or palpitations to your nurse immediately during infusion.
  • Keep a record of your nausea episodes to help your doctor adjust future doses.
  • Do not combine this medication with other drugs that affect heart rhythm without medical advice.

Counselling points

  • AdministrationImportant

    This medication will be given by a nurse in a clinical setting.

  • Side EffectsImportant

    Report any palpitations or dizziness to your doctor immediately.

  • Medication HistoryImportant

    Always inform your doctor about all other medicines you are taking.

  • ConstipationGood to know

    Increase fluid and fiber intake if you experience constipation.

Monitoring during treatment

Before starting

  • ECG for patients with cardiac risk
  • Serum electrolytes (potassium, magnesium)
  • Liver function tests

During treatment

  • during treatment: Monitor heart rhythm and electrolyte levels if symptoms arise.

What is being watched

  • QT interval
  • Heart rate
  • Electrolyte levels
  • Liver enzymes

Pharmacokinetics

Absorption
Rapidly absorbed following oral administration; injection provides immediate bioavailability.
Bioavailability
Approximately 60% with oral, 100% with IV.
Protein binding
70-76%.
Volume of distribution
1.9 L/kg.
Half-life
3 to 5 hours.
Metabolism
Extensive hepatic metabolism via CYP450 enzymes.
Excretion
Primarily via urine as metabolites.
Onset / duration
Onset within minutes; duration 8-12 hours.

Fact box

Chemical class
Carbazolone derivative
Habit forming
No
Therapeutic class
Antiemetic
Action class
Selective 5-HT3 receptor antagonist
Storage
Store in a cool, dry place protected from light. Do not freeze. Keep out of reach of children. Use immediately after opening the ampoule.
ATC code
A04AA01
Pregnancy category
B

More information

Clinical Rationale for Selection

Clinicians select Ondansetron as a first-line agent for emesis prevention because of its superior safety profile compared to older dopamine antagonists like metoclopramide. Unlike those agents, Ondansetron does not cross the blood-brain barrier in a way that causes extrapyramidal symptoms such as tremors or dystonia. This makes it the standard of care for oncology patients who are already experiencing significant physical distress. Its high affinity for 5-HT3 receptors ensures that the vomiting reflex is blocked at the source, providing reliable protection during highly emetogenic chemotherapy regimens.

Comparison with Alternatives

When compared to other antiemetics, Ondansetron is distinguished by its lack of sedative effects. While antihistamines or phenothiazines might be used for nausea, they often cause significant drowsiness, which can hinder a patient's recovery or daily functioning. Newer agents like NK1 receptor antagonists are sometimes used in combination with Ondansetron for highly emetogenic chemotherapy, but Ondansetron remains the backbone of the antiemetic regimen due to its proven efficacy, ease of administration, and well-understood safety profile in both pediatric and adult populations.

Lifestyle and Supportive Care

While receiving treatment with Ondansetron 2mg/ml Injection, patients should focus on maintaining adequate hydration, as nausea can often lead to fluid loss. If constipation occurs, which is a known side effect, increasing dietary fiber and ensuring regular fluid intake is recommended. Patients should avoid strenuous activity immediately after receiving the injection if they feel lightheaded. It is also helpful to keep a log of nausea episodes, as this information is invaluable for the medical team when they are planning subsequent doses or adjusting the treatment strategy for future cycles.

Managing Common Misconceptions

A common misconception is that Ondansetron 2mg/ml Injection will completely eliminate all forms of nausea. While it is highly effective for chemotherapy and surgery-related nausea, it may not be as effective for nausea caused by other factors like motion sickness or certain metabolic disturbances. Patients should also understand that the absence of nausea does not mean the medication has stopped working; it means the medication is successfully preventing the reflex. Finally, patients often worry about the injection itself, but it is a routine procedure that is quick and generally painless when administered by a trained professional.

References

  1. Electronic Medicines Compendium. Ondansetron 2mg/ml Solution for Injection, Summary of Product Characteristics.View sourceAccessed
  2. Pharmacy and Poisons Board Kenya. Setroken Injection, Summary of Product Characteristics.View sourceAccessed
  3. Health Products Regulatory Authority. Ondansetron 2mg/ml Solution for Injection, Summary of Product Characteristics.View sourceAccessed
  4. Medicore Inc. Ondansetron 2mg/ml Injection, Summary of Product Characteristics.View sourceAccessed
  5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. Jaypee Brothers Medical Publishers, 2019.Accessed

Frequently asked questions about Ondansetron

Is Ondansetron 2mg/ml Injection a sedative?

No, Ondansetron 2mg/ml Injection is an antiemetic and does not typically cause sedation.

How long does the effect of the injection last?

The duration of action varies, but it typically provides coverage for several hours.

Can I take this for morning sickness?

It is generally reserved for chemotherapy or surgery-related nausea; consult your doctor for pregnancy-related nausea.

Does it interact with pain killers?

It is generally safe with most common pain killers, but inform your doctor of all medications.

What should I do if I feel dizzy after the injection?

Inform your nurse immediately so they can monitor your blood pressure and heart rate.

Latest